TY - JOUR
T1 - Kinetics of a putative hypoxic tracer, 99mTc-HL91, in normoxic, hypoxic, ischemic, and stunned myocardium
AU - Imahashi, Kenichi
AU - Morishita, Kenichi
AU - Kusuoka, Hideo
AU - Yamamichi, Yoshihiro
AU - Hasegawa, Shinji
AU - Hashimoto, Katsuji
AU - Shirakami, Yoshifumi
AU - Kato-Azuma, Makoto
AU - Nishimura, Tsunehiko
N1 - Copyright:
Copyright 2007 Elsevier B.V., All rights reserved.
PY - 2000/6
Y1 - 2000/6
N2 - 99mTc-4,9-diaza-3,3,10,10-tetramethyldodecan-2,11-dione dioxime (HL91) was developed as a putative hypoxic reagent. This study focused on the myocardial kinetics of 99mTc-HL91 in various oxygen levels and perfusion states. Methods: The time-activity curve of 99mTc-HL91 was measured in isolated perfused rat heart after the bolus infusion. Results: 99mTc-HL91 was cleared quickly from normoxic hearts, and retention at 30 min after injection was 0.18 ± 0.02 percentage injected dose per gram of wet weight (mean ± SE; n = 6). When the concentration of oxygen bubbling through the perfusate was reduced from 100% to 50%, 20%, 5%, and 0%, retention of 99mTc-HL91 increased to 0.47 ± 0.03 (n = 5), 0.48 ± 0.03 (n = 5), 0.71 ± 0.01 (n = 5), and 0.70 ± 0.02 (n = 5), respectively (P < 0.05). Compartment analysis revealed that the trapping mechanism, which was dependent on tissue oxygen concentration, determined the retention rate. Although not retained in stunned myocardium (0.17 ± 0.02, n = 5; P = not significant), 99mTc-HL91 was significantly retained when injected before ischemia (1.06 ± 0.06, n = 5; P < 0.05). Conclusion: These results indicate that retention of 99mTc-HL91 correlates well with oxygen level in the perfusate, suggesting that the agent may be a useful marker of the severity of myocardial hypoxia.
AB - 99mTc-4,9-diaza-3,3,10,10-tetramethyldodecan-2,11-dione dioxime (HL91) was developed as a putative hypoxic reagent. This study focused on the myocardial kinetics of 99mTc-HL91 in various oxygen levels and perfusion states. Methods: The time-activity curve of 99mTc-HL91 was measured in isolated perfused rat heart after the bolus infusion. Results: 99mTc-HL91 was cleared quickly from normoxic hearts, and retention at 30 min after injection was 0.18 ± 0.02 percentage injected dose per gram of wet weight (mean ± SE; n = 6). When the concentration of oxygen bubbling through the perfusate was reduced from 100% to 50%, 20%, 5%, and 0%, retention of 99mTc-HL91 increased to 0.47 ± 0.03 (n = 5), 0.48 ± 0.03 (n = 5), 0.71 ± 0.01 (n = 5), and 0.70 ± 0.02 (n = 5), respectively (P < 0.05). Compartment analysis revealed that the trapping mechanism, which was dependent on tissue oxygen concentration, determined the retention rate. Although not retained in stunned myocardium (0.17 ± 0.02, n = 5; P = not significant), 99mTc-HL91 was significantly retained when injected before ischemia (1.06 ± 0.06, n = 5; P < 0.05). Conclusion: These results indicate that retention of 99mTc-HL91 correlates well with oxygen level in the perfusate, suggesting that the agent may be a useful marker of the severity of myocardial hypoxia.
KW - Hypoxia
KW - Ischemia
KW - Myocardial stunning
KW - Radioisotopes
UR - http://www.scopus.com/inward/record.url?scp=0034082545&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034082545&partnerID=8YFLogxK
M3 - Article
C2 - 10855642
AN - SCOPUS:0034082545
SN - 0161-5505
VL - 41
SP - 1102
EP - 1107
JO - Journal of Nuclear Medicine
JF - Journal of Nuclear Medicine
IS - 6
ER -